Goodwin Procter advised SpringWorks Therapeutics on the deal.SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue and…
SpringWorks Therapeutics’ $300 Million Shares Private Placement
